Enveric Biosciences Inc expected to post a loss of 52 cents a share - Earnings Preview

Enveric Biosciences

08/11/2024 16:03

* Enveric Biosciences Inc  ENVB.OQ   ENVB.O  is expected
to show
no change in quarterly revenue when it reports  results on
November 11 (estimated) for the period ending September 30 2024
    * 
    * ​LSEG's mean analyst estimate for Enveric Biosciences Inc
is for
a loss of 52 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Enveric
Biosciences Inc is 8.32​, above​ its last closing price
of $0.48. ​​​

This summary was machine generated November 8 at 16:01 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)